Last reviewed · How we verify
NCT05383651
Post Market, Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator
trial testing bellavista 1000 in Ventilation Therapy; Complications in 350 participants. Completed in 30 June 2024.
31 May 2024
Quick facts
| Lead sponsor | Vyaire Medical |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 350 |
| Start date | 1 February 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 2 locations across Canada, Switzerland |
Drugs / interventions tested
- bellavista 1000
- bellavista 1000 neo
Conditions studied
- Ventilation Therapy; Complications — all drugs for Ventilation Therapy; Complications →
Sponsor
Vyaire Medical
Who can join
6 Months and older, any sex, with Ventilation Therapy; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective post market clinical follow up (PMCF) study will evaluate the safety and performance of bellavista ventilator and the iFlow sensors in daily clinical routine.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05383651
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ventilation Therapy; Complications
Currently open trials in the same condition.
- NCT06612125 — Comparing Different Startegies of Positive Pressure Ventilation in Children · NA · recruiting
- NCT06142773 — Study to Investigate an Association Between Brain Activity and Tidal Volume in Humans (BATMAN) · NA · recruiting
- NCT04484727 — "Lung Barometric Measurements in Normal And in Respiratory Distressed Lungs" · recruiting
- NCT04498598 — Structural Modification In Supraglottic Airway Device · NA · recruiting
- NCT03439683 — KAP Asynchrony Survey · recruiting
Other Vyaire Medical trials
Trials by the same sponsor.
- NCT05175573 — SuperNO2VA Et Versus Oxygen Face Mask During Deep Sedation · NA · completed
- NCT05229172 — Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG) · completed
- NCT04957472 — Multicenter Study of the Safety and Performance of Fabian-PRICO for Saturation Targeting Routine Use in the NICU · completed
- NCT04709627 — enFlow IV Fluid and Blood Warming System · completed
- NCT03969615 — SuperNO2VA™ and General Anesthesia Postoperative Care · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05383651 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vyaire Medical
- Last refreshed: 5 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05383651.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing